Envafolimab drug page Clinical trials

Trials with Envafolimab

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

9Trials
3Recruiting
1Countries
1.196Planned patients

Showing 1–1 of 1

Neoadjuvant Envafolimab in Resectable and Locally Advanced MSI-H/dMMR Rectal Cancer
Finished 38 patients NCT05645094

This is a single center, prospective, single arm clinical trial to evaluate the efficacy and safety of Envafolimab as a neoadjuvant therapy for resectable and locally advanced dMMR or MSI-H rectal cancer.

Jan 2023 – Jun 2026 Observational

Where the recruiting trials are